News
Loomer had slammed Prasad for allegedly denying drug approvals for rare diseases, and for his past support of left-leaning figures like Senator Bernie Sanders ...
Sources also say that the administration plans to split CBER in two, with one of the section focused entirely on vaccines.
2don MSN
Vinay Prasad vs the FDA: How One Doctor's Policies Collided with Politics and Cost Him His Job
Dr Vinay Prasad, the FDA's Chief Medical and Scientific Officer, resigned from his post on 29 July 2025 after mounting ...
1d
GlobalData on MSNGeorge Tidmarsh to sub in as FDA CBER head following Prasad’s shock exit
Tidmarsh will temporarily guide CBER’s regulatory activities while the FDA searches for a permanent department lead.
Such appeasement efforts proved insufficient to protect him from rival forces in the Republican Party, if not also in the ...
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
Prasad came to the Food & Drug Administration in May, hoping to set high, evidence-based standards for new medicines. He didn't even last three months. The industry's power has never been clearer.
Donald Trump reportedly ignored calls from Health Secretary Robert F. Kennedy Jr. not to fire the top vaccine official at the Food and Drug Administration after a pressure campaign from far-right ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results